#EXP00163

General

Accession EXP00163
Activity Preformed biofilm
Date 2013-11-26
Administration In solution
Model in vitro
Organism Staphylococcus aureus
Status Validated
Notes Sa7 clinical isolate

Peptide

BMAP-28

GGLRSLGRKILRAWKKYGPIIVPIIRI

Experimental activity

Method Concentration Notes
Total countable CFUs 5.207 uM No notes
Crystal violet assay 52.068 uM No notes

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814